Structure |
Chemical Name |
CAS |
MF |
|
4,5-ジヒドロ-Α-(ヒドロキシメチル)-Α,3-ジメチル-5-オキソ-1-フェニル-1H-ピラゾール-4-メタンスルホン酸 |
1242471-40-4 |
C13H16N2O5S |
|
16α,17-[(1RS)-Butylidenebis(oxy)]-11β-hydroxy-17-(hydroxyMethyl)-D-hoMoandrosta-1,4-diene-3,17a-dione (Mixture of DiastereoMers) |
1040085-99-1 |
C25H34O6 |
|
2-ブロモ-1-シクロプロピル-2-(3-フルオロフェニル)エタノン |
1359829-72-3 |
C11H10BrFO |
|
N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetaMide |
198471-06-6 |
C18H16N2O4S |
|
N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
289472-81-7 |
C19H24N4O3 |
|
(Z)-N-(2-nitrovinyl)acetaMide |
1238305-24-2 |
C4H6N2O3 |
|
cefoxitin iMpurity B |
|
|
|
pidotiMod iMpurity A |
|
|
|
Rivaroxaban iMpurity A |
931204-39-6 |
C19H20ClN3O6S |
|
R-7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-Methyl-10-(4-Methyl-1-piperazinyl)-7-oxo- Methyl ester |
1268719-66-9 |
C19H22FN3O4 |
|
Ticagrelor Sulfone |
274693-39-9 |
C23H28F2N6O6S |
|
DesvancosaMinyl VancoMycin |
101485-50-1 |
C59H62Cl2N8O22 |
|
アセトロール |
57898-80-3 |
C14H22N2O3 |
|
RAC-クロピドグレル-MP ENDO誘導(dǎo)體 |
1346598-12-6 |
C25H26ClNO6S |
|
1,1'-N-[Methylenebis(sulphanediylethylene)]bis(N'-Methyl-2-nitroethene-1,1-diaMine |
1331637-48-9 |
C11H22N6O4S2 |
|
2′,3′-ジデオキシ-3′-チアシチジン |
134680-32-3 |
C8H11N3O3S |
|
Formoterol O-β-D-Glucuronide |
615551-59-2 |
C25H32N2O10 |
|
Mono-POC Tenofovir 6-Isopropyl CarbaMate |
1244022-56-7 |
C18H28N5O9P |
|
Ropivacaine Impurity 6 |
|
|
|
Solifenacin ring opening Impurity 11 |
|
|
|
Sugammadex sodium Org210839-1 Impurity |
|
|
|
Sugammadex sodium Org284426-1 Impurity |
|
|
|
Bendamustine Related Impurity 6 |
|
|
|
Butyphthalide impurity 39 |
1841089-57-3 |
C24H28O4 |
|
Butyphthalide impurity 45 |
|
|
|
Dapoxetine impurity 18 |
|
|
|
Febuxostat Impurity 76 |
|
|
|
Febuxostat Impurity 91 |
|
|
|
Ipratropium Bromide Impurity 1 |
|
C20H29Br2NO3 |
|
Lenvatinib Impurity 18 |
|
|
|
Moxifloxacin Impurity 44 |
1048972-52-6 |
C14H12FNO5 |
|
Nintedanib Impurity 32 |
|
|
|
Olsalazine Impurity C |
|
|
|
Parecoxib sodium Impurity 33 |
|
|
|
Tofacitinib Impurity 96 |
|
|
|
Vildagliptin Impurity ZA5 |
|
|
|
Linagliptin Impurity CD10925 |
|
|
|
Nintedanib Impurity N |
|
|
|
(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4- hydroxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate |
1079083-63-8 |
C27H29ClO10 |
|
Vildagliptin Impurity 25 |
1563006-28-9 |
C7H10N2O2 |
|
N-Methyl Iso Desloratadine |
183198-48-3 |
C20H21ClN2 |
|
酒石酸イソプロピルエステル |
116601-09-3 |
C7H12O6 |
|
Vardenafil Acetyl Analogue |
1261351-28-3 |
C25H34N6O3 |
|
fenofibrate iMpurity |
|
|
|
11-O-メチルクラリスロマイシン |
81103-14-2 |
C39H71NO13 |
|
りん酸ENT-オセルタミビル |
1035895-89-6 |
C16H29N2O8P |
|
3-cyano-4-isobutoxybenzaMide |
161718-85-0 |
C12H14N2O2 |
|
カフェイジン酸 |
54536-15-1 |
C8H12N4O3 |
|
1-Keto BaMbuterol |
112935-94-1 |
C18H27N3O5 |
|
デスフルオロエゼチミベ |
302781-98-2 |
C24H22FNO3 |
|
5-(2-Bromo-1-oxobutyl)-8-hydroxy-2(1H)-quinolinone |
59827-93-9 |
C13H12BrNO3 |
|
Ribavirin Related Compound A (15 mg) (1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylic acid) |
39925-19-4 |
C8H11N3O6 |
|
3-(3-TRIFLUOROMETHYL-PHENYL)-PROPYLAMINE |
104774-87-0 |
C10H12F3N |
|
セルトラリンケトン |
124379-29-9 |
C16H12Cl2O |
|
(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3- (4-methoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate |
872980-38-6 |
C28H31ClO10 |
|
Vinorelbine Impurity DX |
89368-94-5 |
C46H55BrN4O8 |
|
1-hydroxypropan-2-yl 2-(2-(4-((4-chlorophenyl)(phenyl)
methyl)piperazin-1-yl)ethoxy)acetate compound with 2-
hydroxypropyl 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)
piperazin-1-yl)ethoxy)acetate (1:1) hydrochloride |
|
|
|
Dapoxetine Impurity 17 |
|
|
|
(4-(2-(アゼパン-1-イル)エトキシ)フェニル)メタノール |
223251-16-9 |
C15H23NO2 |
|
4-ヒドロキシプロポホール |
1988-10-9 |
C12H18O2 |
|
(1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarboxylic acid |
220352-36-3 |
C10H8F2O2 |
|
N1-Methylbenzene-1,2,4-triaMine |
60651-29-8 |
C7H11N3 |
|
RocuroniuMbroMide iMpurity H |
|
|
|
5-chloro-1-(3-diMethylaMinopropyl)-1-(4-fluorophenyl)-phthalan |
64169-45-5 |
C19H21ClFNO |
|
dextroMethorphanone |
|
|
|
oxiracetaM related substance ISF3886 |
120428-80-0 |
C8H13N3O4 |
|
Carvedilol IMpurity D |
1391052-16-6 |
C39H39N3O6 |
|
DL-2-(4-Carboxyphenyl)propionic Acid |
67381-50-4 |
C10H10O4 |
|
ベタメタゾン17-プロピオン酸21-メシル酸 |
15423-80-0 |
C26H35FO8S |
|
12-O-メチルクラリスロマイシン |
128940-83-0 |
C39H71NO13 |
|
3(R)-Hydroperoxy Simvastatin |
1092716-42-1 |
C25H38O7 |
|
10-デアセチル-10-オキソバッカチンV |
151636-94-1 |
C29H34O10 |
|
ドキシルアミン4-ピリジニル異性體 |
873407-01-3 |
C17H22N2O |
|
Clopidogrel EP IMpurity D |
1421283-60-4 |
C24H21Cl2NO4S |
|
Loratadine IMpurity E |
|
C22H23ClN2O2 |
|
Flucloxacillin IMpurity G |
|
|
|
Gefitinib N-Oxide |
847949-51-3 |
C22H24ClFN4O4 |
|
Milrinone IMpurity 3 |
98293-81-3 |
C12H7N3O3 |
|
Nicardipine Related CoMpound 4 |
123973-71-7 |
C25H27N3O6 |
|
PraMipexole IMp.BI-II786BS |
|
|
|
Propofol IMpurity E |
|
|
|
Solifenacin Related CoMpound 5 |
|
|
|
TelMisartan BroMo Ethyl Ester |
133085-87-7 |
C16H15BrO2 |
|
Tolterodine Lactol IMpurity |
209747-04-6 |
C16H16O2 |
|
Valsartan N1-Trityl IMpurity |
|
|
|
(3-Carbamoylallyl)trimethylammonium |
857162-57-3 |
C7H15N2O+ |
|
N-(3-クロロ-4-ヒドロキシフェニル)アセトアミド |
3964-54-3 |
C8H8ClNO2 |
|
ent-14S-3-Methoxy-17-MethylMorphinan |
1453167-99-1 |
C18H25NO |
|
PD 224378 |
501665-88-9 |
C20H35NO11 |
|
(rac,syn)-4-Deschloro-sertraline |
871838-58-3 |
C17H18ClN |
|
1-[2-(DiMethylaMino)-1-phenylethyl]cyclohexanol |
93413-86-6 |
C16H25NO |
|
1-[4-(2-Methoxyethenyl)phenoxy]-3-[(1-Methylethyl)aMino]-2-propanol |
82961-02-2 |
C15H23NO3 |
|
11-Desethyl Irinotecan |
103816-16-6 |
C31H34N4O6 |
|
7-[[[(CyanoMethyl)thio]acetyl]aMino]-7-Methoxy Cephalosporanic Acid |
56796-16-8 |
C15H17N3O7S2 |
|
7S-Cefdinir |
178601-89-3 |
C14H13N5O5S2 |
|
Dehydroxy BroMocelecoxib |
170570-75-9 |
C17H13BrF3N3O2S |
|
Desethylene Norfloxacin Hydrochloride |
75001-77-3 |
C14H16FN3O3 |
|
p-(2,3-Epoxypropoxy)benzyl Alcohol |
4204-78-8 |
C10H12O3 |
|
α-Etoposide |
100007-53-2 |
C29H32O13 |
|
N-Desmethyl-N-benzyl Sildenafil |
1446089-82-2 |
C28H34N6O4S |